SCHEMBL4611278

SCHEMBL4611278

CCOC(=O)Oc1csc(N)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
MAPT P10636 2/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
MAPK1 P28482 1/20 0.45
HTT P42858 2/20 0.45
KDM4E B2RXH2 1/20 0.45
PKM P14618 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TSHR P16473 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 2/20 0.40
NOS1 P29475 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRB2 P47870 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5230966 0.83 SMN1; SMN2 (0.43) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL1831608 0.82 MAPT (0.40) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL27317580 0.82 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL27336449 0.80 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL1493531 0.79 KMT2A (0.38) ALDH1A1MEN1KMT2AMAPTNPC1
Hydrochloric Acid SCHEMBL6216370 0.79 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL1000856 0.78 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL7380565 0.77 ALDH1A1 (0.45) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL10591403 0.77 ALDH1A1 (0.45) ALDH1A1MEN1KMT2AMAPTNPC1
Hydrochloric Acid SCHEMBL11102564 0.76 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910330-B1 HETEROCYCLYLAMIDE-SUBSTITUTED THIAZOLES, PYRROLES AND THIOPHENES AICURIS GMBH & CO KG (DE) 2014-07-23 EP disclosed
EP-1910330-A1 HETEROCYCLYLAMIDE-SUBSTITUTED THIAZOLES, PYRROLES AND THIOPHENES Bayer HealthCare AG (DE) 2008-04-16 EP disclosed
WO-2007009578-A1 HETEROCYCLYLAMIDE-SUBSTITUTED THIAZOLES, PYRROLES AND THIOPHENES BAYER HEALTHCARE AG (DE) 2007-01-25 WO disclosed
EP-1465613-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2004-10-13 EP disclosed
WO-2003057205-A2 COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-07-17 WO disclosed
WO-2003004020-A1 HETEROARYL CARBOXYLIC ACID AMIDES, THE PRODUCTION THEREOF AND THE USE OF THE SAME AS INHIBITORS OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-01-16 WO disclosed
EP-1073638-A1 HETEROCYCLICALLY SUBSTITUTED AMIDES, THEIR PRODUCTION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 2001-02-07 EP disclosed
WO-1999054304-A1 HETEROCYCLICALLY SUBSTITUTED AMIDES, THEIR PRODUCTION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1999-10-28 WO disclosed